WATS3D utilizes a powerful combination of enhanced wide area sampling, 3D imaging with AI neural network analysis and expert GI pathologists - resulting in more precise diagnoses.
See How WATS3D Works
EAC incidence rise is almost unchanged in the United States, resulting in a 700+% increase over the past 40 years. Esophageal cancer continues to be one of the deadliest (~80% 5-year mortality rate).
Seattle protocol lacks utility and confidence, being time-consuming with low physician adherence. Random sampling covers only a fraction of the esophagus, leaving ~94% uncovered, prone to sampling error.
.
3-tiered approach with enhanced wide-area tissue acquisition and AI analysis overcomes sampling error, reduces pathological misses, and empowers WATS3D GI pathologists to render a more precise diagnosis.
ASGE Practice Guideline:
“In this document, the ASGE offers evidence-based clinical practice guidelines on topics regarding screening and surveillance for BE.” “In patients with known or suspected BE, we suggest using WATS3D in addition to WLE with Seattle protocol biopsy sampling compared with WLE with Seattle protocol biopsy sampling alone.”
“Wide-area trans-epithelial sampling with three-dimensional computer-assisted analysis (WATS 3D , CDx Diagnostics) is a safe and effective adjunct to forcep biopsies in the evaluation of Barrett’s esophagus, LGD, and HGD." SAGES TAVAC
“The American Foregut Society (AFS) Board has concluded that there are sufficient data to support the routine use of WATS3D technology in the diagnosis and ongoing evaluation of Barrett’s esophagus.”
WATS3D Streamlined Process
Make your patient's next EGD more reliable
WATS3D has consistently demonstrated reliable detection of more Barrett's esophagus and dysplasia than standard biopsy methods alone.
ACCESS THE SUMMARY OF PUBLICATIONS
WATS3D utilizes a powerful combination of enhanced wide area sampling, 3D imaging with AI neural network analysis and expert GI pathologists - resulting in more precise diagnoses.
[Watch the "How WATS3D Works" Video ]
Still have questions about WATS3D? Our team is here to ensure a smooth and informative experience. Feel free to reach out with any inquiries or feedback, or give us a call at 866-3636-CDx (239).
Wide-area transepithelial sampling with computer-assisted 3-dimensional analysis (WATS) markedly improves detection of esophageal dysplasia and Barrett's esophagus: analysis from a prospective multicenter community-based study.
Michael S. Smith, Erkanda Ikonomi, Rajiv Bhuta, Natalya Iorio, Rahul D. Kataria, Vivek Kaul, Seth A. Gross; US Collaborative WATS3D Study Group
Diseases of the Esophagus, March 2019
Utility of wide-area transepithelial sampling with 3-dimensional computer-assisted analysis as an adjunct to forceps biopsy sampling in the surveillance of patients with Barrett’s esophagus after endoscopic eradication therapy.
F. Scott Corbett, Robert D. Odze, Matthew J. McKinley
iGIE, December 2022
Adjunctive study at 121 community-based sites
Benefit of Adjunctive Wide Area Transepithelial Sampling with 3-Dimensional Computer- Assisted Analysis Plus Forceps Biopsy Based on Barrett’s Esophagus Segment Length.
Arvind J. Trindade, Robert D. Odze, Michael S. Smith, Vivek Kaul
Gastrointestinal Endoscopy, March 2023
©2025 CDx Diagnostics. All Rights Reserved.